Login / Signup

Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter].

Muhammad Hamza ShujaMuhammad Sohaib Khan
Published in: International journal of general medicine (2023)
Keyphrases
  • cardiovascular events
  • coronary artery disease
  • cardiovascular disease
  • type diabetes
  • adverse drug